SS18 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.718840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.902600E-01
Normal-vs-Stage2
1.740250E-01
Normal-vs-Stage3
2.461200E-03
Normal-vs-Stage4
5.739400E-01
Stage1-vs-Stage2
8.469000E-01
Stage1-vs-Stage3
6.882100E-02
Stage1-vs-Stage4
3.336400E-01
Stage2-vs-Stage3
3.836300E-02
Stage2-vs-Stage4
2.171200E-01
Stage3-vs-Stage4
6.990700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.648020E-01
Normal-vs-AfricanAmerican
8.793000E-01
Normal-vs-Asian
3.273600E-02
Caucasian-vs-AfricanAmerican
9.783800E-02
Caucasian-vs-Asian
9.073500E-02
AfricanAmerican-vs-Asian
2.933600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.839180E-01
Normal-vs-Female
1.688250E-01
Male-vs-Female
9.567200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.745400E-01
Normal-vs-Age(41-60Yrs)
5.308000E-01
Normal-vs-Age(61-80Yrs)
8.207800E-02
Normal-vs-Age(81-100Yrs)
4.482200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.308800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.206600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.173600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.356270E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.261900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.996200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.799700E-02
Normal-vs-Daily Drinker
5.399800E-02
Normal-vs-Weekly Drinker
3.118300E-02
Normal-vs-Occasional Drinker
4.030000E-01
Normal-vs-Social Drinker
3.417000E-01
Non Drinker-vs-Daily Drinker
7.877600E-01
Non Drinker-vs-Weekly Drinker
3.991200E-01
Non Drinker-vs-Occasional Drinker
1.530120E-02
Non Drinker-vs-Social Drinker
5.362100E-02
Daily Drinker-vs-Weekly Drinker
5.289400E-01
Daily Drinker-vs-Occasional Drinker
2.731700E-02
Daily Drinker-vs-Social Drinker
8.410200E-02
Weekly Drinker-vs-Occasional Drinker
9.706500E-02
Weekly Drinker-vs-Social Drinker
2.253800E-01
Occasional Drinker-vs-Social Drinker
7.437600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.656600E-01
Normal-vs-Grade 2
1.443970E-01
Normal-vs-Grade 3
1.313220E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.540600E-01
Grade 1-vs-Grade 3
7.092600E-01
Grade 1-vs-Grade 4
2.656600E-01
Grade 2-vs-Grade 3
7.670200E-01
Grade 2-vs-Grade 4
1.443970E-01
Grade 3-vs-Grade 4
1.313220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.566300E-02
Normal-vs-NonDiabetic
1.652190E-01
Diabetic-vs-NonDiabetic
6.528300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.602300E-02
Normal-vs-NoPancreatitis
1.583350E-01
Pancreatitis-vs-NoPancreatitis
8.662100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.421600E-01
Normal-vs-N1
1.454370E-01
N0-vs-N1
8.919200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.333400E-01
Normal-vs-TP53-NonMutant
2.761400E-01
TP53-Mutant-vs-TP53-NonMutant
5.958600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
